Pharmaceutical Science cmte. heads down “Critical Path”
FDA's Advisory Committee for Pharmaceutical Science will discuss "Critical Path" initiative research opportunities on the first day if its Oct. 19-20 meeting. On Oct. 20, the committee will discuss implementation of the risk-based GMP initiative and generic drug equivalence issues. The meeting will be held at the CDER Advisory Committee conference room, 5630 Fishers Lane in Rockville, Md. beginning at 8:30 a.m. both days. [Editor's Note: To 1watch a webcast or order a video/DVD of this meeting, visit FDAAdvisoryCommittee.com.]...
You may also be interested in...
Prescience Point Capital is trying to reshuffle the board of directors leading regenerative medicine company MiMedx, arguing the company’s current board has destroyed shareholder value. The company's tock is selling for about a third of its potential value, according to Prescience.
Unilever’s Suave brand led new sanitizer product sales in 2020, when hand sanitizers total sales grew 569%, according to IRI. Sales of rinseable hand-soap sales grew 64% and antiseptics 19%.
The pandemic has exacerbated the problems of the Turkish medical device industry, which was already struggling for survival and growth in a hostile policy environment. Local blood bag manufacturer Kansuk Laboratory talked to Medtech Insight about the difficulties it faces.